赛国生物取得GlpBIo 一级代理权。Glpbio是新启的世界领先的高性能的生命科学产品供应商之一，产品涵盖癌症、神经科学、抗感染、表观遗传学等20个热门研究领域，覆盖Akt、Jak等近千个细分靶点。
      Glpbio创立于2016年，总部设在美国加州Montclair，与很多客户都已建立起长期稳定的关系，主要客户包括世界各大制药厂，生物科技公司，医院及各大临床诊断实验室，世界各著名高校、研究所以及政府机构等。
     Glpbio目前提供超过10000种包括GPCR配体、神经递质、离子通路和信号抑制物等在内的化学小分子和多肽等生命科学研究试剂，并且每周定期增加各领域热门抑制剂、激动剂，不断扩增已有化合物，以满足最新的科研需求。

     Glpbio作为生命科学领域的抑制剂专家，产品具有良好的纯度，稳定性和生物活性。Glpbio核心理念就是“保证每一个产品的质量”，致力于为生物医学研究提供完善的研究资料和可靠的产品性能，产品已被全球客户广泛使用。Glpbio的宗旨是，使世界各地的科学家更容易获得最具创新性的生命科学试剂，并帮助他们更快地做出重大的科学发现。这些化合物在人类疾病的临床前期研究中都具有广泛的应用，具有广泛的潜在用途。

       Saiguo Biologics has obtained the first-tier distributorship of GlpBIo.
       Glpbio is one of the newly launched world-leading suppliers of high-performance life science products covering 20 popular research areas such as cancer, neuroscience, anti-infection, epigenetics, etc., covering nearly 1,000 niche targets such as Akt and Jak.
       Founded in 2016 and headquartered in Montclair, California, Glpbio has established long-term and stable relationships with many customers, including major pharmaceutical companies, biotechnology companies, hospitals and major clinical diagnostic laboratories, world-renowned universities, research institutes and government agencies.
       Glpbio currently offers more than 10,000 life science research reagents including chemical small molecules and peptides including GPCR ligands, neurotransmitters, ion pathways and signal inhibitors, etc. Glpbio also regularly adds popular inhibitors and agonists in various fields every week and continuously expands existing compounds to meet the latest research needs.
       Glpbio's core philosophy is "Quality in every product", and we are committed to providing complete research materials and reliable product performance for biomedical research, and our products are widely used by customers worldwide. Glpbio's mission is to make the most innovative life science reagents more accessible to scientists around the world and to help them make significant scientific discoveries faster. Each of these compounds has a wide range of potential applications in preclinical studies of human diseases.

【2022/12/12 15:25:07】